BioSig amends 8-K to provide Streamex business overview, risk factors, and pro forma financials

Streamex Corp.

Streamex generated ~$200,000 revenue in Q1 2025; platform still under development with no tokenized assets launched.
Streamex to tokenize real-world assets starting with gold; competes with Pax Gold ($810M cap) and Securitize ($4B+ tokenized).
BioSig now operates two segments: healthcare (PURE EP/ViralClear) and tokenized finance through Streamex.
Streamex holds minority interest in Canadian Exempt Market Dealer license; tokens likely classified as securities.
Pro forma combined financials filed for periods ended March 31, 2025 and December 31, 2024.

item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.